Regidor PA - Search Results

1

Obesity and contraceptive use: impact on cardiovascular risk.

Rosano GMC, Rodriguez-Martinez MA, Spoletini I, Regidor PA. Rosano GMC, et al. Among authors: regidor pa. ESC Heart Fail. 2022 Dec;9(6):3761-3767. doi: 10.1002/ehf2.14104. Epub 2022 Sep 14. ESC Heart Fail. 2022. PMID: 36103980 Free PMC article. Review.

2

Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill.

Palacios S, Colli E, Regidor PA. Palacios S, et al. Among authors: regidor pa. Acta Obstet Gynecol Scand. 2019 Dec;98(12):1549-1557. doi: 10.1111/aogs.13688. Epub 2019 Aug 6. Acta Obstet Gynecol Scand. 2019. PMID: 31321765 Free PMC article. Clinical Trial.

3

Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime.

Palacios S, Colli E, Regidor PA. Palacios S, et al. Among authors: regidor pa. BMC Womens Health. 2020 Oct 2;20(1):218. doi: 10.1186/s12905-020-01080-9. BMC Womens Health. 2020. PMID: 33008401 Free PMC article. Clinical Trial.

4

Overall and bleeding-related discontinuation rates of a new oral contraceptive containing 4 mg drospirenone only in a 24/4 regimen and comparison to 0.075 mg desogestrel.

Regidor PA, Colli E, Palacios S. Regidor PA, et al. Gynecol Endocrinol. 2021 Dec;37(12):1121-1127. doi: 10.1080/09513590.2021.1963432. Epub 2021 Aug 17. Gynecol Endocrinol. 2021. PMID: 34402728 Clinical Trial.

5

Bleeding profile of women with cardiovascular risk factors using a drospirenone only pill with 4 mg over nine cycles compared to desogestrel 0.075 mg.

Regidor PA, Palacios S, Colli E. Regidor PA, et al. Gynecol Endocrinol. 2022 Apr;38(4):333-338. doi: 10.1080/09513590.2022.2046729. Epub 2022 Mar 9. Gynecol Endocrinol. 2022. PMID: 35261299

6

Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone.

Regidor PA, Schindler AE. Regidor PA, et al. Oncotarget. 2017 Aug 3;8(47):83334-83342. doi: 10.18632/oncotarget.19833. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137347 Free PMC article. Review.

7

In vitro evaluation of microbial adhesion to a contraceptive vaginal ring with a new polymer composition.

Sailer M, Colli E, Regidor PA. Sailer M, et al. Among authors: regidor pa. Eur J Contracept Reprod Health Care. 2019 Jun;24(3):188-191. doi: 10.1080/13625187.2019.1595575. Epub 2019 Apr 12. Eur J Contracept Reprod Health Care. 2019. PMID: 30977415

8

The clinical relevance of progestogens in hormonal contraception: Present status and future developments.

Regidor PA. Regidor PA. Oncotarget. 2018 Oct 2;9(77):34628-34638. doi: 10.18632/oncotarget.26015. eCollection 2018 Oct 2. Oncotarget. 2018. PMID: 30349654 Free PMC article. Review.

9

Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature.

Palacios S, Regidor PA, Colli E, Skouby SO, Apter D, Roemer T, Egarter C, Nappi RE, Skřivánek A, Jakimiuk AJ, Weyers S, Ács N, Elia D, Gemzell Danielsson K, Bitzer J. Palacios S, et al. Among authors: regidor pa. Eur J Contracept Reprod Health Care. 2020 Jun;25(3):221-227. doi: 10.1080/13625187.2020.1743828. Epub 2020 Apr 21. Eur J Contracept Reprod Health Care. 2020. PMID: 32312141 Review.

10

The progestin-only pills drospirenone 4 mg and desogestrel 0.075 mg as an option for the management of dysmenorrhea and mastodynia.

Regidor PA, Colli E. Regidor PA, et al. Gynecol Endocrinol. 2022 Nov;38(11):978-982. doi: 10.1080/09513590.2022.2134339. Epub 2022 Oct 20. Gynecol Endocrinol. 2022. PMID: 36265507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page